Loading clinical trials...
Loading clinical trials...
The purpose of this study is to characterize the natural history and clinical management of Acute Hepatic Porphyria (AHP) patients with recurring attacks.
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Alnylam Pharmaceuticals
NCT04883905 · Acute Hepatic Porphyria
NCT04923516 · Acute Hepatic Porphyria
NCT04056481 · Acute Hepatic Porphyria
NCT03547297 · Acute Hepatic Porphyria, Hepatic Porphyrias, and more
Clinical Trial Site
San Francisco, California
Clinical Trial Site
Miami, Florida
Clinical Trial Site
Ann Arbor, Michigan
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions